June 29, 2020 / 6:20 PM / 10 days ago

BRIEF-Immunoprecise Antibodies Announces Identification Of Many Lead Candidate Antibodies With Highly-Potent Neutralizing Activity In Vitro

June 29 (Reuters) - Immunoprecise Antibodies Ltd:

* IMMUNOPRECISE ANTIBODIES - ANNOUNCED IDENTIFICATION OF MANY LEAD CANDIDATE ANTIBODIES WITH HIGHLY-POTENT NEUTRALIZING ACTIVITY IN VITRO

* IMMUNOPRECISE - LEAD CANDIDATE ANTIBODIES ARE BEING MANUFACTURED FOR FURTHER TESTING,POSSIBLE INCLUSION IN CO’S POLYTOPE MAB THERAPY TO COMBAT COVID-19

* IMMUNOPRECISE ANTIBODIES - ANTICIPATES PRE-CLINICAL STUDIES WILL BEGIN SUMMER 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below